Literature DB >> 8737240

Influence of phospholipid chain length on verotoxin/globotriaosyl ceramide binding in model membranes: comparison of a supported bilayer film and liposomes.

S Arab1, C A Lingwood.   

Abstract

The importance of the surrounding lipid environment on the availability of glycolipid carbohydrate for ligand binding was demonstrated by studying the influence of phosphatidylcholine fatty acid chain length on binding of verotoxins (VT1 and VT2c) to their specific cell surface receptor, globotriaosylceramide (Gb3) in the presence of auxiliary lipids both in a microtitre plate surface bilayer film and in a liposome membrane model system. In the microtitre assay, both VT1 and VT2c binding to Gb3 was increased as a function of decreasing PC acyl chain length likely resulting in increased Gb3 exposure. In the liposome assay VT1 binding was similarly modulated, however the effect of VT2c binding was more complex and did not follow a simple function of increased carbohydrate exposure. Earlier work established that C22:1 and C18:1Gb3 fatty acid homologues were the preferred Gb3 receptor containing liposomes, but in C14PC liposomes, binding to C22:1Gb3 (but not C18:1Gb3) was elevated such that this Gb3 species now became the preferred receptor for both toxins. This change in verotoxin/Gb3 homologue binding selectivity in the presence of C14PC did not occur in the microtitre bilayer format. These results are consistent with our proposal that these toxins recognize different epitopes on the Gb3 oligosaccharide. We infer that relative availability of these epitopes for toxin binding in an artificial bilayer is influenced not only by the exposure due to the discrepancy between the fatty acyl chain lengths of Gb3 and PC, but by the physical mode of presentation of the bilayer structure. Such acyl chain length differences have a more marked effect in a supported bilayer film whereas only the largest discrepancies affect Gb3 receptor function in liposomes. The basis of phospholipid modulation of glycolipid carbohydrate accessibility for receptor function is likely complex and will involve phase separation, gel/liquid crystalline transition, packing and lateral mobility within the bilayer, suggesting that such parameters should be considered in the assessment of glycolipid receptor function in cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8737240     DOI: 10.1007/bf00731490

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  60 in total

1.  Optimization of antigen presentation to T cell hybridomas by purified Ia molecules in planar membranes. Ia molecule polymorphism determines the antigenic fine specificity of the response to cytochrome c peptides.

Authors:  H Quill; L Carlson; B S Fox; J N Weinstein; R H Schwartz
Journal:  J Immunol Methods       Date:  1987-04-02       Impact factor: 2.303

2.  Possible role of ceramide in defining structure and function of membrane glycolipids.

Authors:  R Kannagi; E Nudelman; S Hakomori
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

3.  Determination of conformational properties of glycolipid head groups by 2H NMR of oriented multibilayers.

Authors:  H C Jarrell; P A Jovall; J B Giziewicz; L A Turner; I C Smith
Journal:  Biochemistry       Date:  1987-04-07       Impact factor: 3.162

4.  Orientation of the saccharide chains of glycolipids at the membrane surface: conformational analysis of the glucose-ceramide and the glucose-glyceride linkages using molecular mechanics (MM3).

Authors:  P G Nyholm; I Pascher
Journal:  Biochemistry       Date:  1993-02-09       Impact factor: 3.162

5.  Glycosphingolipid receptor function is modified by fatty acid content. Verotoxin 1 and verotoxin 2c preferentially recognize different globotriaosyl ceramide fatty acid homologues.

Authors:  A Kiarash; B Boyd; C A Lingwood
Journal:  J Biol Chem       Date:  1994-04-15       Impact factor: 5.157

6.  Development of verotoxin 2- and verotoxin 2 variant (VT2v)-specific oligonucleotide probes on the basis of the nucleotide sequence of the B cistron of VT2v from Escherichia coli E32511 and B2F1.

Authors:  J H Hii; C Gyles; T Morooka; M A Karmali; R Clarke; S De Grandis; J L Brunton
Journal:  J Clin Microbiol       Date:  1991-12       Impact factor: 5.948

7.  Modelling of the interaction of verotoxin-1 (VT1) with its glycolipid receptor, globotriaosylceramide (Gb3).

Authors:  P G Nyholm; J L Brunton; C A Lingwood
Journal:  Int J Biol Macromol       Date:  1995-06       Impact factor: 6.953

8.  Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro.

Authors:  C A Lingwood; H Law; S Richardson; M Petric; J L Brunton; S De Grandis; M Karmali
Journal:  J Biol Chem       Date:  1987-06-25       Impact factor: 5.157

9.  Escherichia coli K99 binds to N-glycolylsialoparagloboside and N-glycolyl-GM3 found in piglet small intestine.

Authors:  M Kyogashima; V Ginsburg; H C Krivan
Journal:  Arch Biochem Biophys       Date:  1989-04       Impact factor: 4.013

10.  Pathogenesis of shigella diarrhea. XI. Isolation of a shigella toxin-binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide.

Authors:  M Jacewicz; H Clausen; E Nudelman; A Donohue-Rolfe; G T Keusch
Journal:  J Exp Med       Date:  1986-06-01       Impact factor: 14.307

View more
  16 in total

Review 1.  Shiga toxins--from cell biology to biomedical applications.

Authors:  Ludger Johannes; Winfried Römer
Journal:  Nat Rev Microbiol       Date:  2009-12-21       Impact factor: 60.633

2.  Lipid sorting by ceramide structure from plasma membrane to ER for the cholera toxin receptor ganglioside GM1.

Authors:  Daniel J-F Chinnapen; Wan-Ting Hsieh; Yvonne M te Welscher; David E Saslowsky; Lydia Kaoutzani; Eelke Brandsma; Ludovic D'Auria; Hyejung Park; Jessica S Wagner; Kimberly R Drake; Minchul Kang; Thomas Benjamin; M David Ullman; Catherine E Costello; Anne K Kenworthy; Tobias Baumgart; Ramiro H Massol; Wayne I Lencer
Journal:  Dev Cell       Date:  2012-09-11       Impact factor: 12.270

3.  Effect of globotriaosyl ceramide fatty acid alpha-hydroxylation on the binding by verotoxin 1 and verotoxin 2.

Authors:  Beth Binnington; Daniel Lingwood; Anita Nutikka; Clifford A Lingwood
Journal:  Neurochem Res       Date:  2002-08       Impact factor: 3.996

4.  Structure-dependent pseudoreceptor intracellular traffic of adamantyl globotriaosyl ceramide mimics.

Authors:  Mitsumasa Saito; Murugespillai Mylvaganum; Patty Tam; Anton Novak; Beth Binnington; Clifford Lingwood
Journal:  J Biol Chem       Date:  2012-03-14       Impact factor: 5.157

Review 5.  Facing glycosphingolipid-Shiga toxin interaction: dire straits for endothelial cells of the human vasculature.

Authors:  Andreas Bauwens; Josefine Betz; Iris Meisen; Björn Kemper; Helge Karch; Johannes Müthing
Journal:  Cell Mol Life Sci       Date:  2012-07-06       Impact factor: 9.261

6.  Tumor necrosis factor alpha increases human cerebral endothelial cell Gb3 and sensitivity to Shiga toxin.

Authors:  P B Eisenhauer; P Chaturvedi; R E Fine; A J Ritchie; J S Pober; T G Cleary; D S Newburg
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

7.  The ether lipid precursor hexadecylglycerol protects against Shiga toxins.

Authors:  Jonas Bergan; Tore Skotland; Anne Berit Dyve Lingelem; Roger Simm; Bjørn Spilsberg; Toril Lindbäck; Tuulia Sylvänne; Helena Simolin; Kim Ekroos; Kirsten Sandvig
Journal:  Cell Mol Life Sci       Date:  2014-04-18       Impact factor: 9.261

8.  Structure and function of a ganglioside receptor for porcine rotavirus.

Authors:  M D Rolsma; T B Kuhlenschmidt; H B Gelberg; M S Kuhlenschmidt
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

9.  Fatty acid-dependent globotriaosyl ceramide receptor function in detergent resistant model membranes.

Authors:  Radhia Mahfoud; Adam Manis; Clifford A Lingwood
Journal:  J Lipid Res       Date:  2008-08-20       Impact factor: 5.922

10.  Lipid reorganization induced by Shiga toxin clustering on planar membranes.

Authors:  Barbara Windschiegl; Alexander Orth; Winfried Römer; Ludwig Berland; Bahne Stechmann; Patricia Bassereau; Ludger Johannes; Claudia Steinem
Journal:  PLoS One       Date:  2009-07-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.